Invagen Pharmaceuticals recalled Lanthanum Carbonate chewable tablets on October 24, 2025, due to stability issues. The tablets failed hardness specifications, posing a high hazard level. Healthcare providers and consumers should stop using the product immediately.
Failed stability specifications: Out of specification for hardness test
Consumers and healthcare providers should stop using this product immediately. Contact Cipla USA, Inc. or your healthcare provider for guidance. Notification method: N/A
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Lanthanum Carbonate chewable tablets are used to manage phosphate levels in patients with chronic kidney disease. Consumers typically purchase this medication as part of a treatment regimen for managing their condition.
The product's failure in hardness testing means that the tablets may not dissolve properly in the body. This could lead to inadequate treatment for patients requiring phosphate control.
This recall is not part of a broader industry pattern.
Consumers may face health risks if they continue using the affected product. Immediate cessation is necessary to avoid potential complications.
Lot numbers and expiration dates are typically found on the bottom of the bottle or carton.
Allow 4-6 weeks for processing of refunds or replacements.
Maintain records of your purchase, including receipts and any communication with the manufacturer.
The recall affects Lanthanum Carbonate chewable tablets, 1000mg per tablet. The product is sold in patient pack cartons containing ten 9-bottle units. The NDC codes are 76282-478-90 for the carton and 76282-478-13 for the bottle.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalled certain 2025 CX-70 vehicles on July 10, 2026. The recall addresses improper inverter software that may cause loss of drive power in EV mode. This defect increases the risk of a crash, prompting immediate action from owners.
Mazda North American Operations recalled certain 2024-2025 CX-90 vehicles due to electrical system malfunctions. The recall affects models equipped with a Dash Electrical Supply Unit (ESU) that may not function properly during startup. Owners should seek repairs immediately to avoid crash risks.
Subaru of America, Inc. recalled certain 2025 Forester vehicles on July 6, 2026. The recall affects child seat anchor bolts that may be improperly tightened. A loose anchor increases the risk of injury to children during a crash.
Nissan North America, Inc. recalled certain 2025 Pathfinder vehicles due to faulty brake calipers on July 3, 2026. This defect can lead to a loss of front brake function, significantly increasing crash risk. Owners received notification letters on May 9, 2025.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
BMW of North America is recalling 2025-2026 X1 and X2 vehicles due to damaged seat belt retractors. The recall affects MINI Cooper and Countryman models as well. Owners will receive notification letters by November 7, 2025.